Diuretic MAG3 scintirenography in children with HIV nephropathy: diffuse parenchymal dysfunction

Area of Science:

• Pediatric Nephrology
• Nuclear Medicine
• Diagnostic Imaging

Background:

• HIV nephropathy (HIVN) affects 15%-56% of HIV-infected children, causing progressive kidney damage.
• Early detection and monitoring of HIVN are crucial for managing renal impairment in pediatric patients.

Purpose of the Study:

• To evaluate the utility of diuretic 99mTc-mercaptoacetyltriglycine (MAG3) scintigraphy in assessing renal function in pediatric patients with HIVN.
• To compare scintigraphic findings with laboratory data and sonography in HIVN patients.

Main Methods:

• Retrospective analysis of 33 renal scintigraphic studies using 99mTc-MAG3 in 23 pediatric HIV patients (21 with HIVN).
• Comparison of scintigraphic parameters (kidney size, uptake, retention) with control groups and laboratory data (creatinine clearance).
• Correlation of scintigraphic results with concurrent sonographic findings in a subset of patients.

Main Results:

• HIVN patients often presented with enlarged kidneys and diffuse parenchymal dysfunction, including reduced uptake and delayed excretion, similar to other diffuse kidney diseases.
• Statistically significant differences in all semiquantitative scintigraphic variables were observed between HIVN patients and controls.
• Scintigraphy revealed abnormalities in HIVN patients where sonography showed none, suggesting higher sensitivity for detecting functional impairment.

Conclusions:

• Diuretic MAG3 scintigraphy demonstrates nonspecific diffuse renal parenchymal dysfunction in pediatric HIVN.
• The test can corroborate HIVN diagnosis and aid in monitoring disease progression and treatment response.
• Further research is required to establish the sensitivity and correlation of MAG3 scintigraphy with HIVN severity.